Dorfman L, Nassar R, Ohana DB, et al. - In children and adolescents with inflammatory bowel disease (IBD), researchers sought to evaluate the impact of the coronavirus disease (COVID-19) pandemic on healthcare provision, fear of infection, adherence to medical treatment, and compliance with preventative instructions in the present study. All pediatric patients with IBD from a single tertiary medical center underwent a cross-sectional telephone survey using a Likert scale-based questionnaire. Among the 244 pediatric patients with IBD involved in the research, a high rate of fear of severe COVID-19 infection due to IBD or IBD medications was reported. Ministry of Health instructions were obeyed by most patients(228, 93.4%), while almost 50% took additional protective measures, including avoiding school and complete lockdown. Other frequently reported concerns were attendance of regular clinics (116, 47.5%) and emergency room in case of IBD exacerbation (178, 73%). A change or discontinuation of IBD treatment due to COVID-19 was reported by only 7 patients (2.9%). Several distinct features of the pandemic impact of COVID-19 on pediatric IBD patients have been reported, including a high rate of fear of severe COVID-19 infection, fear of attending necessary medical facilities, and a high rate of social activity avoidance.